FDA preparing to clear roughly 10 million Johnson & Johnson Covid-19 vaccine doses
CNN
The Food and Drug Administration is preparing to clear two batches of Johnson & Johnson Covid-19 vaccines that were produced at the troubled Emergent facility in Baltimore, a source familiar with the plans told CNN.
This is a significant development, given not a single usable dose of the Johnson & Johnson Covid-19 vaccine from that facility has been approved yet. Around 10 million doses are expected to be included in these batches.More Related News
Tulsi Gabbard, Donald Trump’s pick to lead the intelligence community, was briefly placed on a Transportation Security Administration list that prompts additional security screening before flights after her overseas travel patterns and foreign connections triggered a government algorithm earlier this year, three sources familiar with the matter told CNN.